Silvia Casas
Overview
Explore the profile of Silvia Casas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loupy A, Certain A, Tangprasertchai N, Racape M, Ursule-Dufait C, Benbadi K, et al.
Transpl Int
. 2025 Jan;
37:13919.
PMID: 39741495
Donor-derived cell-free DNA (dd-cfDNA) is an emerging non-invasive biomarker for allograft injury detection. This study aimed to evaluate a new, decentralized dd-cfDNA testing kit against a centralized dd-cfDNA testing service...
2.
Casas S, Tangprasertchai N, Oikonomaki K, Mathers S, Calderin Sollet Z, Samara S, et al.
HLA
. 2024 May;
103(5):e15518.
PMID: 38733247
Donor-derived cell-free DNA (dd-cfDNA) has been widely studied as biomarker for non-invasive allograft rejection monitoring. Earlier rejection detection enables more prompt diagnosis and intervention, ultimately improving patient treatment and outcomes....
3.
Mantios E, Filiopoulos V, Constantoulakis P, Liapis G, Vittoraki A, Casas S, et al.
Transpl Int
. 2023 Oct;
36:11507.
PMID: 37901296
In our prospective, unicenter cohort study, we collected blood samples from 30 newly kidney transplanted patients, at month 1, 2, 3, and 5 for dd-cfDNA analysis, along with creatinine/eGFR and...
4.
Cucchiari D, Cuadrado-Payan E, Gonzalez-Roca E, Revuelta I, Argudo M, Ramirez-Bajo M, et al.
Nephrol Dial Transplant
. 2023 Sep;
39(1):114-121.
PMID: 37715343
Background: Ischemia-reperfusion injury (IRI) upon transplantation is one of the most impactful events that the kidney graft suffers during its life. Its clinical manifestation in the recipient, delayed graft function...
5.
Mayer K, Doberer K, Halloran P, Budde K, Haindl S, Muhlbacher J, et al.
Transplant Direct
. 2022 Nov;
8(12):e1406.
PMID: 36382130
Methods: We report a secondary endpoint analysis of a phase 2 trial of anti-IL-6 antibody clazakizumab in late AMR (ClinicalTrials.gov, NCT03444103). Twenty kidney transplant recipients were randomized to treatment with...
6.
Mayer K, Omic H, Weseslindtner L, Doberer K, Reindl-Schwaighofer R, Viard T, et al.
Clin Transplant
. 2022 Jul;
36(11):e14785.
PMID: 35894263
Background: BK polyomavirus-associated nephropathy (BKPyVAN) carries a risk of irreversible allograft injury. While detection of BK viremia and biopsy assessment are the current diagnostic gold standard, the diagnostic value of...
7.
Mayer K, Doberer K, Tillgren A, Viard T, Haindl S, Krivanec S, et al.
Transpl Int
. 2021 Aug;
34(9):1689-1702.
PMID: 34448270
Circulating donor-specific antibodies (DSA) do not necessarily indicate antibody-mediated rejection (ABMR). Here, we evaluated the diagnostic value of donor-derived cell-free DNA (dd-cfDNA) as an add-on to DSA detection. The study...
8.
Radin M, Foddai S, Cecchi I, Rubini E, Barinotti A, Mahler M, et al.
Thromb Res
. 2021 Apr;
202:100-103.
PMID: 33798802
No abstract available.
9.
Sciascia S, Radin M, Ramirez C, Seaman A, Bentow C, Casas S, et al.
Autoimmun Rev
. 2020 Aug;
19(10):102641.
PMID: 32801044
Patients with antiphospholipid syndrome (APS) present with clinical features of recurrent thrombosis and pregnancy morbidity and persistently test positive for the presence of antiphospholipid antibodies (aPL). At least one clinical...
10.
Mahler M, Hudson M, Bentow C, Roup F, Beretta L, Simeon C, et al.
Autoimmun Rev
. 2020 Jun;
19(8):102583.
PMID: 32553611
Systemic sclerosis (SSc) is a rare chronic disease of unknown etiology characterized by vascular abnormalities and fibrosis involving the skin and internal organs, especially the gastrointestinal tract, lung, heart and...